Robert F. Kennedy Jr. proposes expanding access to experimental medical treatments, acknowledging potential risks from unlicensed providers. Is this a step forward or a danger to public health?
A cautionary tale from a geriatrician reveals the risks of cannabis gummies for seniors. A 76-year-old's experience highlights the importance of proper dosage and awareness of drug interactions.
A new study reveals a drastic decline in maternal mental health, with only 25.8% of mothers reporting ‘excellent’ mental health in 2023. Experts warn of long-term effects on children and the urgent need for better support.
In an unprecedented medical achievement, a child with a rare genetic disorder receives a customized CRISPR gene therapy, paving the way for future treatments of similar conditions.
In a groundbreaking achievement, scientists have developed the first gene-editing medicine tailored for a baby suffering from a rare DNA condition. After successful treatments, KJ Muldoon is now healthier and ready to go home, showcasing a promising future for gene therapies.
Researchers have developed a groundbreaking method for inserting large genes into specific locations in human cells, potentially transforming the field of gene therapy and opening new avenues in medical research.
Ever wondered what lurks in your snacks? New research reveals that synthetic chemicals from packaging and processing could pose serious health risks. Discover the hidden dangers in your food and what needs to change.
In a groundbreaking case, a 6-month-old baby boy named KJ was treated with a personalized CRISPR gene-editing therapy, correcting a dangerous mutation before it could threaten his life. This innovative approach promises hope for similar cases.
A baby diagnosed with a rare genetic disorder has shown remarkable improvement after receiving an experimental gene editing treatment tailored just for him. This groundbreaking therapy offers hope for others with similar conditions.
KJ Muldoon, born with a deadly genetic disorder, received a groundbreaking CRISPR treatment just six months after birth. His remarkable progress showcases the future of personalized medicine for rare diseases.
